X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-phase-2b-trial-efficacy-and-safety-results-of-novel-presbyopia-eye-drop-candidate-csf-1-at-the-2022-american-society-of-cataract-and-refractive-surgery-ascrs-annual-meeting-301530823.html
https://endpts.com/orasis-will-ship-its-vuity-eye-drop-competitor-to-the-fda-later-this-year-with-two-phiii-wins/
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-positive-phase-3-topline-results-of-novel-eye-drop-candidate-csf-1-for-the-treatment-of-presbyopia-301529894.html
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-to-present-new-data-on-novel-presbyopia-candidate-at-the-2022-american-society-of-cataract-and-refractive-surgery-ascrs-annual-meeting-301523497.html
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-concludes-phase-3-clinical-trials-for-presbyopia-candidate-301502727.html
Market Place
Share 
